Efficacy and safety of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors as monotherapy or add-on to metformin in patients with type 2 diabetes mellitus: A systematic review and meta-analysis

Wang, ZY; Sun, JH; Han, RB; Fan, DZ; Dong, XY; Luan, ZH; Xiang, RW; Zhao, MY; Yang, JY

Zhao, MY; Yang, JY (reprint author), Shenyang Pharmaceut Univ, Dept Clin Pharm, Shenyang 110016, Liaoning, Peoples R China.

DIABETES OBESITY & METABOLISM, 2018; 20 (1): 113

Abstract

AimsTo compare the efficacy and safety of dipeptidyl peptidase-4 inhibitors (DPP-4is) and sodium-glucose cotransporter-2 inhibitors (SGLT-2is) as mono......

Full Text Link